What is Alaxin used for?

Alaxin is indicated for Malaria.

Alaxin is developed by Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.

What development phase is Alaxin in?

Alaxin is FDA-approved (marketed).

What is the generic name of Alaxin?

ARTENIMOL is the generic (nonproprietary) name of Alaxin.

Last reviewed 2026-04-20 · How we verify

Alaxin (ARTENIMOL)

Sigma-Tau Industrie Farmaceutiche Riunite S.p.A · FDA-approved active Small molecule Quality 25/100

At a glance

Generic name	ARTENIMOL
Sponsor	Sigma-Tau Industrie Farmaceutiche Riunite S.p.A
Drug class	artenimol
Modality	Small molecule
Therapeutic area	Immunology
Phase	FDA-approved

Approved indications

Malaria

Common side effects

No common side effects on file.

Key clinical trials

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) (PHASE2)
Efficacy of Dihydroartemisinin for Treating Acne Vulgaris (EARLY_PHASE1)
Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL (PHASE2)
Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants (PHASE2)
Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia (PHASE3)
Efficacy of Dihydroartemisinin for Treating PCOS (PHASE2)
Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome (PHASE2)
The Effect of Dihydroartemisinin in PCOS (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Alaxin CI brief — competitive landscape report
Alaxin updates RSS · CI watch RSS
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A portfolio CI